Your browser doesn't support javascript.
loading
Reprogramming enriches for somatic cell clones with small-scale mutations in cancer-associated genes.
Kosanke, Maike; Osetek, Katarzyna; Haase, Alexandra; Wiehlmann, Lutz; Davenport, Colin; Schwarzer, Adrian; Adams, Felix; Kleppa, Marc-Jens; Schambach, Axel; Merkert, Sylvia; Wunderlich, Stephanie; Menke, Sandra; Dorda, Marie; Martin, Ulrich.
Afiliación
  • Kosanke M; Leibniz Research Laboratories for Biotechnology and Artificial Organs (LEBAO), Department of Cardiothoracic, Transplantation and Vascular Surgery, REBIRTH - Research Center for Translational Regenerative Medicine, Hannover Medical School, 30625 Hannover, Germany, Biomedical Research in Endstage and
  • Osetek K; Leibniz Research Laboratories for Biotechnology and Artificial Organs (LEBAO), Department of Cardiothoracic, Transplantation and Vascular Surgery, REBIRTH - Research Center for Translational Regenerative Medicine, Hannover Medical School, 30625 Hannover, Germany, Biomedical Research in Endstage and
  • Haase A; Leibniz Research Laboratories for Biotechnology and Artificial Organs (LEBAO), Department of Cardiothoracic, Transplantation and Vascular Surgery, REBIRTH - Research Center for Translational Regenerative Medicine, Hannover Medical School, 30625 Hannover, Germany, Biomedical Research in Endstage and
  • Wiehlmann L; Research Core Unit Genomics, Hannover Medical School, 30625 Hannover, Germany.
  • Davenport C; Research Core Unit Genomics, Hannover Medical School, 30625 Hannover, Germany.
  • Schwarzer A; Department of Hematology, Oncology and Stem Cell Transplantation, Institute of Experimental Hematology, REBIRTH - Research Center for Translational Regenerative Medicine, Hannover Medical School, 30625 Hannover, Germany.
  • Adams F; Department of Hematology, Oncology and Stem Cell Transplantation, Institute of Experimental Hematology, REBIRTH - Research Center for Translational Regenerative Medicine, Hannover Medical School, 30625 Hannover, Germany.
  • Kleppa MJ; Department of Hematology, Oncology and Stem Cell Transplantation, Institute of Experimental Hematology, REBIRTH - Research Center for Translational Regenerative Medicine, Hannover Medical School, 30625 Hannover, Germany.
  • Schambach A; Department of Hematology, Oncology and Stem Cell Transplantation, Institute of Experimental Hematology, REBIRTH - Research Center for Translational Regenerative Medicine, Hannover Medical School, 30625 Hannover, Germany.
  • Merkert S; Leibniz Research Laboratories for Biotechnology and Artificial Organs (LEBAO), Department of Cardiothoracic, Transplantation and Vascular Surgery, REBIRTH - Research Center for Translational Regenerative Medicine, Hannover Medical School, 30625 Hannover, Germany, Biomedical Research in Endstage and
  • Wunderlich S; Leibniz Research Laboratories for Biotechnology and Artificial Organs (LEBAO), Department of Cardiothoracic, Transplantation and Vascular Surgery, REBIRTH - Research Center for Translational Regenerative Medicine, Hannover Medical School, 30625 Hannover, Germany, Biomedical Research in Endstage and
  • Menke S; Leibniz Research Laboratories for Biotechnology and Artificial Organs (LEBAO), Department of Cardiothoracic, Transplantation and Vascular Surgery, REBIRTH - Research Center for Translational Regenerative Medicine, Hannover Medical School, 30625 Hannover, Germany, Biomedical Research in Endstage and
  • Dorda M; Research Core Unit Genomics, Hannover Medical School, 30625 Hannover, Germany.
  • Martin U; Leibniz Research Laboratories for Biotechnology and Artificial Organs (LEBAO), Department of Cardiothoracic, Transplantation and Vascular Surgery, REBIRTH - Research Center for Translational Regenerative Medicine, Hannover Medical School, 30625 Hannover, Germany, Biomedical Research in Endstage and
Mol Ther ; 29(8): 2535-2553, 2021 08 04.
Article en En | MEDLINE | ID: mdl-33831558

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Células Clonales / Células Madre Pluripotentes Inducidas / Secuenciación del Exoma / Mutación / Neoplasias Tipo de estudio: Risk_factors_studies Límite: Aged / Humans Idioma: En Revista: Mol Ther Asunto de la revista: BIOLOGIA MOLECULAR / TERAPEUTICA Año: 2021 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Células Clonales / Células Madre Pluripotentes Inducidas / Secuenciación del Exoma / Mutación / Neoplasias Tipo de estudio: Risk_factors_studies Límite: Aged / Humans Idioma: En Revista: Mol Ther Asunto de la revista: BIOLOGIA MOLECULAR / TERAPEUTICA Año: 2021 Tipo del documento: Article